These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 34002026)

  • 61. Efficacy of Tocilizumab in COVID-19: Single-Center Experience.
    Kaya S; Kavak S
    Biomed Res Int; 2021; 2021():1934685. PubMed ID: 34977235
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study.
    Aljuhani O; Al Sulaiman K; Alshabasy A; Eljaaly K; Al Shaya AI; Noureldeen H; Aboudeif M; Al Dosari B; Alkhalaf A; Korayem GB; Aleissa MM; Badreldin HA; Al Harbi S; Alhammad A; Vishwakarma R
    BMC Infect Dis; 2021 Nov; 21(1):1127. PubMed ID: 34724920
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [COVID-19: Still a place for tocilizumab?].
    Richier Q; Plaçais L; Lacombe K; Hermine O
    Rev Med Interne; 2021 Feb; 42(2):73-78. PubMed ID: 33288230
    [No Abstract]   [Full Text] [Related]  

  • 64. Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis.
    Keske Ş; Akyol M; Tanrıöver C; Özlüşen B; Akcan RE; Güler U; Sait B; Kaçmaz B; Gönen M; Ergönül Ö
    Infection; 2023 Dec; 51(6):1619-1628. PubMed ID: 37162716
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tocilizumab; A Potential Remedy Against The Ever-Evolving Threat Of Coronavirus-2 (SARS-Cov-2).
    Ali Malik GM; Faheem S
    J Pak Med Assoc; 2023 Aug; 73(8):1776-1777. PubMed ID: 37697798
    [No Abstract]   [Full Text] [Related]  

  • 66. Re: 'Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis' by Tleyjeh et al.
    Koeckerling D; Pan D; Barker J
    Clin Microbiol Infect; 2021 Aug; 27(8):1175-1176. PubMed ID: 33549765
    [No Abstract]   [Full Text] [Related]  

  • 67. Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials.
    Ghaempanah F; Nikouei M; Cheraghi M; Jahangiri A; Moradi Y
    J Pharm Policy Pract; 2023 Nov; 16(1):151. PubMed ID: 37986199
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of tocilizumab treatment in severely ill COVID-19 patients.
    Zhao J; Cui W; Tian BP
    Crit Care; 2020 Aug; 24(1):524. PubMed ID: 32854738
    [No Abstract]   [Full Text] [Related]  

  • 69. Impact of alcohol consumption on coronavirus disease 2019 severity: A systematic review and meta-analysis.
    Wei B; Liu Y; Li H; Peng Y; Luo Z
    J Med Virol; 2023 Feb; 95(2):e28547. PubMed ID: 36734064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adverse Effects of Tocilizumab Versus Baricitinib in Severe COVID-19.
    Leaf DE; Gordon AC; Lawler PR
    Crit Care Med; 2023 Sep; 51(9):e184-e185. PubMed ID: 37589523
    [No Abstract]   [Full Text] [Related]  

  • 71. Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19.
    Kow CS; Ramachandram DS; Hasan SS
    Ann Pharmacother; 2023 Nov; 57(11):1341-1342. PubMed ID: 37002589
    [No Abstract]   [Full Text] [Related]  

  • 72. Safety of Tocilizumab and Remdesivir in Treating COVID-19 Pneumonia in Premature Twins.
    Bihm D; Huang J; Yi B; Posch L; Brown D; Lai KC
    Pediatrics; 2023 Apr; 151(4):. PubMed ID: 36893339
    [No Abstract]   [Full Text] [Related]  

  • 73. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial: Erratum.
    Crit Care Med; 2023 Aug; 51(8):e177. PubMed ID: 37439653
    [No Abstract]   [Full Text] [Related]  

  • 74. Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials.
    Snow TAC; Saleem N; Ambler G; Nastouli E; Singer M; Arulkumaran N
    Intensive Care Med; 2021 Jun; 47(6):641-652. PubMed ID: 34019122
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tocilizumab in the treatment of COVID-19-a meta-analysis.
    Avni T; Leibovici L; Cohen I; Atamna A; Guz D; Paul M; Gafter-Gvili A; Yahav D
    QJM; 2021 Nov; 114(8):577-586. PubMed ID: 34010403
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis.
    Petrelli F; Cherri S; Ghidini M; Perego G; Ghidini A; Zaniboni A
    World J Methodol; 2021 May; 11(3):95-109. PubMed ID: 34026583
    [TBL] [Abstract][Full Text] [Related]  

  • 77. No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study.
    Burlacu R; London J; Fleury A; Sené T; Diallo A; Meyssonnier V; Zeller V; Galland J; Huscenot T; Rubenstein E; Trouiller P; Amathieu R; Kutter J; Blondeel D; Lejour G; Mouly S; Lidove O; Wladimir M; Sène D
    Medicine (Baltimore); 2021 May; 100(21):e26023. PubMed ID: 34032722
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Corticosteroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Pulakurthi YS; Pederson JM; Saravu K; Gupta N; Balasubramanian P; Kamrowski S; Schmidt M; Vegivinti CTR; Dibas M; Reierson NL; Pisipati S; Joseph BA; Selvan PT; Dmytriw AA; Keesari PR; Sriram V; Chittajallu S; Brinjikji W; Katamreddy RR; Chibbar R; Davis AR; Malpe M; Mishra HK; Kallmes KM; Hassan AE; Evanson KW
    Medicine (Baltimore); 2021 May; 100(20):e25719. PubMed ID: 34011029
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis.
    Singhal S; Kumar P; Singh S; Saha S; Dey AB
    BMC Geriatr; 2021 May; 21(1):321. PubMed ID: 34011269
    [TBL] [Abstract][Full Text] [Related]  

  • 80. COVID-19: breaking down a global health crisis.
    Mallah SI; Ghorab OK; Al-Salmi S; Abdellatif OS; Tharmaratnam T; Iskandar MA; Sefen JAN; Sidhu P; Atallah B; El-Lababidi R; Al-Qahtani M
    Ann Clin Microbiol Antimicrob; 2021 May; 20(1):35. PubMed ID: 34006330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.